Special Cases in Acute Heart Failure Syndromes: Atrial Fibrillation and Wide Complex Tachycardia
Tài liệu tham khảo
Fonarow, 2005, Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis, JAMA, 293, 572, 10.1001/jama.293.5.572
Fonarow, 2007, Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from acute decompensated heart failure national registry (ADHERE), Am Heart J, 153, 1021, 10.1016/j.ahj.2007.03.012
Fonarow, 2007, Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry, J Am Coll Cardiol, 50, 768, 10.1016/j.jacc.2007.04.064
Gheorghiade, 2005, Acute heart failure syndromes: current state and framework for future research, Circulation, 112, 3958, 10.1161/CIRCULATIONAHA.105.590091
Nieminen, 2005, Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology, Eur Heart J, 26, 384, 10.1093/eurheartj/ehi044
Gheorghiade, 2006, Congestion in acute heart failure syndromes: an essential target of evaluation and treatment, Am J Med, 119, S3, 10.1016/j.amjmed.2006.09.011
Adams, 2005, Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE), Am Heart J, 149, 209, 10.1016/j.ahj.2004.08.005
ADHERE Scientific Advisory Committee. Acute Decompensated Heart Failure National Registry (ADHERE) Core Module Q1 2006 final cumulative national benchmark report. In: Scios, Inc, 2006.
Fonarow, 2003, The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure, Rev Cardiovasc Med, 4, S21
Khand, 2000, Systematic review of the management of atrial fibrillation in patients with heart failure, Eur Heart J, 21, 614, 10.1053/euhj.1999.1767
Chicos, 2008, Arrhythmia in acute heart failure
Doval, 1996, Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators, Circulation, 94, 3198, 10.1161/01.CIR.94.12.3198
Teerlink, 2000, Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death, Circulation, 101, 40, 10.1161/01.CIR.101.1.40
Fuster, 2006, J Am Coll Cardiol, 48, 854, 10.1016/j.jacc.2006.07.009
Heart Failure Society of America, 2006, Executive summary: HFSA 2006 comprehensive heart failure practice guideline, J Card Fail, 12, 10, 10.1016/j.cardfail.2005.12.001
Hunt, 2005, Circulation, 112, e154, 10.1161/CIRCULATIONAHA.105.167586
Crijns, 2000, Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure, Eur Heart J, 21, 1238, 10.1053/euhj.1999.2107
Efremidis, 2008, Management of atrial fibrillation in patients with heart failure, J Card Fail, 14, 232, 10.1016/j.cardfail.2007.10.023
Folkeringa, 2004, Prognosis of atrial fibrillation in congestive heart failure, Circulation, 109, e11, 10.1161/01.CIR.0000111134.23909.DB
Heist, 2006, Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment, Prog Cardiovasc Dis, 48, 256, 10.1016/j.pcad.2005.09.001
Wang, 2003, Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, Circulation, 107, 2920, 10.1161/01.CIR.0000072767.89944.6E
Wasywich, 2006, Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure, Heart Lung Circ, 15, 353, 10.1016/j.hlc.2006.07.011
Cain, 2002, Atrial fibrillation: rhythm or rate control, N Engl J Med, 347, 1822, 10.1056/NEJMp020134
Van Gelder, 2002, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N Engl J Med, 347, 1834, 10.1056/NEJMoa021375
Wyse, 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328
Al-Khatib, 2004, Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?, Am J Cardiol, 94, 797, 10.1016/j.amjcard.2004.06.009
Kareti, 2005, Congestive heart failure and atrial fibrillation: rhythm versus rate control, J Card Fail, 11, 164, 10.1016/j.cardfail.2004.09.011
AF-CHF Investigators, 2002, Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial, Am Heart J, 144, 597, 10.1016/S0002-8703(02)00129-1
Hagens, 2005, Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control Versus Electrical Cardioversion (RACE) study, Am Heart J, 149, 1106, 10.1016/j.ahj.2004.11.030
Van den Berg, 1997, Heart failure and atrial fibrillation: current concepts and controversies, Heart, 77, 309, 10.1136/hrt.77.4.309
Benjamin, 1994, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study, JAMA, 271, 840, 10.1001/jama.271.11.840
Cleland, 2003, The EuroHeart failure survey programme–a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis, Eur Heart J, 24, 442, 10.1016/S0195-668X(02)00823-0
Tavazzi, 2006, Nationwide survey on acute heart failure in cardiology ward services in Italy, Eur Heart J, 27, 1207, 10.1093/eurheartj/ehi845
Siirila-Waris, 2006, Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure, Eur Heart J, 27, 3011, 10.1093/eurheartj/ehl407
Bentancur, 2002, Acute pulmonary edema in the emergency department: clinical and echocardiographic survey in an aged population, Am J Med Sci, 323, 238, 10.1097/00000441-200205000-00002
Podrid P, Ganz L. Approach to the diagnosis and treatment of wide QRS complex tachycardia. Available at: www.UpToDate.com, Vol Online 15.3. Accessed October 1, 2008.
Zannad, 1999, Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine, J Am Coll Cardiol, 33, 734, 10.1016/S0735-1097(98)00634-2
Rudiger, 2005, Acute heart failure: clinical presentation, one-year mortality and prognostic factors, Eur J Heart Fail, 7, 662, 10.1016/j.ejheart.2005.01.014
Fonarow, 2004, Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design, Am Heart J, 148, 43, 10.1016/j.ahj.2004.03.004
O'Connor, 2005, Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry, J Card Fail, 11, 200, 10.1016/j.cardfail.2004.08.160
Cuffe, 2002, Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial, JAMA, 287, 1541, 10.1001/jama.287.12.1541
VMAC Investigators, 2002, Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial, JAMA, 287, 1531, 10.1001/jama.287.12.1531
Follath, 2002, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial, Lancet, 360, 196, 10.1016/S0140-6736(02)09455-2
Torre-Amione, 2003, Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure, J Am Coll Cardiol, 42, 140, 10.1016/S0735-1097(03)00556-4
O'Connor, 2003, Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the randomized intravenous TeZosentan study (RITZ-4), J Am Coll Cardiol, 41, 1452, 10.1016/S0735-1097(03)00194-3
Kaluski, 2003, RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study, J Am Coll Cardiol, 41, 204, 10.1016/S0735-1097(02)02708-0
Burger, 2002, Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study, Am Heart J, 144, 1102, 10.1067/mhj.2002.125620
Gattis, 2004, Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (IMPACT-HF) trial, J Am Coll Cardiol, 43, 1534, 10.1016/j.jacc.2003.12.040
The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group, 1997, Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients, Eur Heart J, 18, 649, 10.1093/oxfordjournals.eurheartj.a015311
Hou, 1995, Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone: a randomized, digoxin-controlled study, Eur Heart J, 16, 521, 10.1093/oxfordjournals.eurheartj.a060945
Clemo, 1998, Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias, Am J Cardiol, 81, 594, 10.1016/S0002-9149(97)00962-4
Kumar, 1996, Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function, South Med J, 89, 779, 10.1097/00007611-199608000-00005
Andrivet, 1994, A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia, Eur Heart J, 15, 1396, 10.1093/oxfordjournals.eurheartj.a060401
Goldenberg, 1994, Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure, Am J Cardiol, 74, 884, 10.1016/0002-9149(94)90580-0
Heywood, 1991, Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure, Am J Cardiol, 67, 1150, 10.1016/0002-9149(91)90885-O